MK-4334

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK-4334, covering 2024-11-29 to 2025-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) [Phase 1]